Aspiriant LLC’s VeriSign VRSN Stock Holding History

Aspiriant LLC’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-747	Closed	-$216K	–	320
2025 Q2	$216K	Buy	+747	New	+$202K	0.01%	298

Other funds holding VRSN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Aspiriant LLC's VRSN Position: Q3 2025 in Review

Aspiriant LLC sold out of VeriSign (VRSN) in Q3 2025, closing a stake of 747 shares — an estimated $216K sold.

Aspiriant LLC first reported a position in VRSN in Q2 2025 and held it in 1 quarter. The position peaked at $216K in Q2 2025. 854 funds tracked by Wall St. Rank hold VRSN as of Q3 2025.

Aspiriant LLC reported no remaining VeriSign position as of Q3 2025 after selling out during the quarter.
Aspiriant LLC sold 747 VeriSign shares in Q3 2025, an estimated $216K.
Aspiriant LLC first reported a position in VeriSign in Q2 2025 and held it in 1 quarter.
Aspiriant LLC's VeriSign position peaked at $216K in Q2 2025.
854 funds tracked by Wall St. Rank held VeriSign as of Q3 2025.

Based on Aspiriant LLC's 13F filing for Q3 2025, filed 24 Oct 2025.